No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia

Background: Preeclampsia, the most common serious complication of pregnancy, is characterized by vasoconstriction, dysfunction of the vascular endothelium, and hypertension. Unidentified genetic factors and impaired nitric oxide (NO)-mediated vasodilation are thought to contribute to the development of the syndrome. Polymorphisms of the endothelial nitric oxide synthase (eNOS) gene affect NO production and have been associated with hypertension and preeclampsia in a Japanese population. Methods: We compared the frequency of the Glu298Asp eNOS polymorphism in 397 Hispanic and white normotensive pregnant control subjects with the gene frequencies in 64 women with preeclampsia (systolic blood pressure > 140 mm Hg or diastolic blood pressure >90 mm Hg, on at least two occasions 6 hours apart, and proteinuria >0.3 g/L or a dipstick proteinuria reading of 2+). Results: Preeclampsia was not associated with the presence of Asp at position 298 of eNOS. Conclusions: In contrast to the findings in Japanese women, preeclampsia was not associated with the Asp variant of eNOS in an American population. (C) 2004 American Journal of Hypertension, Ltd.